Canada· CA-DIN-02371588
OVIDREL
A choriogonadotropin alfa product containing choriogonadotropin alfa, registered in Canada by EMD SERONO, A DIVISION OF EMD INC., CANADA. The same ATC class is registered in 14 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Choriogonadotropin alfa is registered in 14 of 19 countries.
Countries holding a registration under ATC G03GA08 (choriogonadotropin alfa), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 9 of them publish a price we can compare per daily dose
Choriogonadotropin alfa · ATC G03GA08
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- CHORIOGONADOTROPIN ALFA
- Manufacturer
- EMD SERONO, A DIVISION OF EMD INC., CANADA
- Country
- Canada (CA)
- ATC code
- G03GA08
- ATC class
- Choriogonadotropin alfa
- Defined daily dose
- 0.25 mg, P
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Choriogonadotropin alfa in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandOvitrelleMerck Europe B.V.
- NorwayOvitrelleMerck Europe B.V.
- United KingdomOvitrelle 250microgram powder and solvent for solution for injection vialsMerck Serono Ltd
- SwedenOvitrelle 250 mikrogram/0,5 ml Injektionsvätska, lösning i förfylld injektionspennaMerck Europe B.V.
- IrelandOvitrelle 250 micrograms solution for injection in pre-filled penMerck Europe B.V.
- IcelandOvitrelleMerck Europe B.V.*
- CzechiaOVITRELLEMerck Europe B.V., Amsterdam
- NetherlandsOvitrelle 250 microgram oplossing voor injectie in voorgevulde penMerck Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ovitrelle
- Liechtenstein · Ovitrelle
- Norway · Ovitrelle
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b5d4920d-9984-4fab-9c0d-6b28cb28c968 GET /v1/drugs/b5d4920d-9984-4fab-9c0d-6b28cb28c968?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02371588",
"form": "SOLUTION",
"class": "Human",
"routes": [
"SUBCUTANEOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "G03GA08",
"schedule": [
"Schedule D",
"Prescription"
],
"drug_code": "85673",
"strengths": [
"250 MCG"
],
"ahfs_class": null,
"substances": [
"CHORIOGONADOTROPIN ALFA"
],
"product_categorization": null
}See everything about choriogonadotropin alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.